VBI Vaccines
VBIV
#10452
Rank
A$2.67 M
Marketcap
A$0.09322
Share price
0.00%
Change (1 day)
-90.33%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$14.47. In 2022 the company made an earnings per share (EPS) of A-$18.84 a decrease over its 2021 EPS that were of A-$11.56.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$18.8462.96%
2021A-$11.5628.57%
2020A-$8.99-54.35%
2019A-$19.70-52.58%
2018A-$41.5410.23%
2017A-$37.6914.29%
2016A-$32.98-62.8%
2015A-$88.6590.68%
2014A-$46.49-7.95%
2013A-$50.51-57.97%
2012A-$120.19-78%
2011A-$546.383151.47%
2010A-$16.8023.87%
2009A-$13.57-18.48%
2008A-$16.6412.08%
2007A-$14.85-49.47%
2006A-$29.39
2005N/A-100%
2004A-$13.0611.94%
2003A-$11.67-81.89%
2002A-$64.44196.44%
2001A-$21.7484.33%
2000A-$11.79-65.37%
1999A-$34.06-29.45%
1998A-$48.2729.61%
1997A-$37.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.36-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.24-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.18-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA